Baxter Announces Vantive as the Name of Proposed Kidney Care Spinoff
Yahoo! Finance
DEERFIELD, Ill., July 25, 2023--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses. Vantive is expected to launch as an independent, publicly traded company by July 2024 or earlier, subject to satisfaction of customary conditions.
Continue Reading